Market Indices
Sector Heatmap
GANX — Gain Therapeutics, Inc. Common Stock
NasdaqGain Therapeutics, Inc. Common Stock
- O
- 1.75
- H
- 1.78
- L
- 1.70
- V
- 381.17K
GANX — Latest News & Headlines
7 StoriesLong-term data on a Parkinson’s drug candidate will be presented in Seoul. - Stock Titan
Long-term data on a Parkinson’s drug candidate will be presented in Seoul. Stock Titan
VSAT Stock Clocks Best Day In Over 10 Months — Analyst Calls It ‘Last Major Global Satellite Spectrum Play’ After Rocket Lab-Iridium Deal - Stocktwits
VSAT Stock Clocks Best Day In Over 10 Months — Analyst Calls It ‘Last Major Global Satellite Spectrum Play’ After Rocket Lab-Iridium Deal Stocktwits
Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration - markets.businessinsider.com
Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration markets.businessinsi...
Form 8K Gain Therapeutics Inc For: 28 September By Investing.com - Investing.com South Africa
Form 8K Gain Therapeutics Inc For: 28 September By Investing.com Investing.com South Africa
Gain Therapeutics reports stable motor scores in Parkinson’s trial By Investing.com - Investing.com UK
Gain Therapeutics reports stable motor scores in Parkinson’s trial By Investing.com Investing.com UK
Gain Therapeutics Names CEO as Interim CFO - TipRanks
Gain Therapeutics Names CEO as Interim CFO TipRanks
Gain Therapeutics highlights promising Parkinson’s Phase 1b data - TipRanks
Gain Therapeutics highlights promising Parkinson’s Phase 1b data TipRanks